Published in Oncogene on June 29, 2009
MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A. Oncotarget (2015) 1.22
RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy. Dermatol Res Pract (2011) 1.15
AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Invest Dermatol (2012) 1.09
B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma. J Invest Dermatol (2013) 1.07
c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines. PLoS One (2010) 1.00
Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. BMC Cancer (2010) 0.94
Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell lines. Genes Genomics (2014) 0.84
The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies. Orphanet J Rare Dis (2015) 0.83
Prognostic molecular biomarkers for cutaneous malignant melanoma. J Surg Oncol (2011) 0.82
RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb. Oncotarget (2015) 0.81
Central role of RET in thyroid cancer. Cold Spring Harb Perspect Biol (2013) 0.79
ERG transcriptional networks in primary acute leukemia cells implicate a role for ERG in deregulated kinase signaling. PLoS One (2013) 0.78
Epigenetic regulation of REG1A and chemosensitivity of cutaneous melanoma. Epigenetics (2013) 0.78
The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma. Melanoma Res (2012) 0.78
Proteomic Identification of DNA-PK Involvement within the RET Signaling Pathway. PLoS One (2015) 0.77
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer? Cancers (Basel) (2015) 0.76
Kinase Gene Fusions in Defined Subsets of Melanoma. Pigment Cell Melanoma Res (2016) 0.75
Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis. Mod Pathol (2015) 0.75
Suppression of Poly(rC)-Binding Protein 4 (PCBP4) reduced cisplatin resistance in human maxillary cancer cells. Sci Rep (2015) 0.75
A multikinase and DNA-PK inhibitor combination immunomodulates melanomas, suppresses tumor progression, and enhances immunotherapies. Cancer Immunol Res (2017) 0.75
Epigenetic Regulation of KPC1 Ubiquitin Ligase Effects the NF-κB Pathway in Melanoma. Clin Cancer Res (2017) 0.75
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol (2006) 7.76
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science (1993) 6.73
The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci (2002) 5.93
Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res (2003) 4.03
Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer (2006) 3.83
BAY 43-9006 inhibition of oncogenic RET mutants. J Natl Cancer Inst (2006) 3.61
New insight into BRAF mutations in cancer. Curr Opin Genet Dev (2007) 2.40
Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J Clin Invest (2007) 2.22
Cancer phenomics: RET and PTEN as illustrative models. Nat Rev Cancer (2006) 2.13
Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer (1998) 2.12
Retracted The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest (2005) 2.09
The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev (2001) 2.05
Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas. Clin Cancer Res (2004) 2.05
Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene (1988) 1.95
Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference. Oncogene (2004) 1.76
Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol (2005) 1.71
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial. J Clin Oncol (2005) 1.37
Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy. Clin Cancer Res (2007) 1.33
Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases. Ann Med (2007) 1.32
Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence. Oncogene (1989) 1.28
Cutaneous desmoplastic melanoma. Adv Anat Pathol (2005) 1.27
RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. J Clin Endocrinol Metab (2004) 1.26
Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys (2004) 1.25
Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Oncogene (2005) 1.24
Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther (2008) 1.23
DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene. Oncogene (1994) 1.22
The clinical behavior of desmoplastic melanoma. Am J Surg (2001) 1.21
In vivo selection for metastasis promoting genes in the mouse. Proc Natl Acad Sci U S A (2007) 1.20
Absence of V599E BRAF mutations in desmoplastic melanomas. Cancer (2005) 1.17
The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling. Cancer Res (2005) 1.14
Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients. Cancer Res (1999) 1.14
Sorafenib functions to potently suppress RET tyrosine kinase activity by direct enzymatic inhibition and promoting RET lysosomal degradation independent of proteasomal targeting. J Biol Chem (2007) 1.13
cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily. Oncogene (1993) 1.09
A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy. Cancer Res (2006) 1.08
The RET proto-oncogene: a molecular therapeutic target in thyroid cancer. Cancer Sci (2005) 1.04
Inhibition of RET tyrosine kinase by SU5416. J Mol Endocrinol (2006) 0.99
Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patients. J Invest Dermatol (2001) 0.90
Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling. J Invest Dermatol (2005) 0.89
Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue. Br J Cancer (2002) 0.81
Update on the molecular diagnosis of endocrine tumors: toward -omics-based personalized healthcare? J Clin Endocrinol Metab (2008) 0.80
Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma. Thyroid (2005) 0.79
Geometric control of cell life and death. Science (1997) 18.13
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg (1994) 8.85
E.coli Fis protein activates ribosomal RNA transcription in vitro and in vivo. EMBO J (1990) 4.57
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg (1995) 4.37
Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A (1996) 4.20
Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol (1995) 4.16
Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members. Oncogene (2008) 4.13
Strong, constitutive expression of the Arabidopsis ACT2/ACT8 actin subclass in vegetative tissues. Plant J (1996) 4.08
Cellular factors couple recombination with growth phase: characterization of a new component in the lambda site-specific recombination pathway. Cell (1987) 3.94
How a protein binds B12: A 3.0 A X-ray structure of B12-binding domains of methionine synthase. Science (1994) 3.93
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet (2009) 3.87
Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem (1998) 3.80
Impaired immunologic reactivity and recurrence following cancer surgery. Cancer (1970) 3.77
Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg (1995) 3.62
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
S proteins control rejection of incompatible pollen in Petunia inflata. Nature (1994) 3.54
Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med (1993) 3.48
Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol (1997) 3.35
Changes in Amino Acid Content of Excised Leaves During Incubation. III. Role of Sugar in the Accumulation of Proline in Wilted Leaves. Plant Physiol (1966) 3.18
The premature ageing syndrome protein, WRN, is a 3'-->5' exonuclease. Nat Genet (1998) 3.12
Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood (1991) 3.12
How stable is stable? Function versus community composition. Appl Environ Microbiol (1999) 3.08
Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev (1995) 2.97
Control of directionality in lambda site specific recombination. Science (1985) 2.91
IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol (1989) 2.86
Noise pollution in the anaesthetic and intensive care environment. Anaesthesia (1994) 2.86
Anaerobic Accumulation of gamma-Aminobutyric Acid and Alanine in Radish Leaves (Raphanus sativus, L.). Plant Physiol (1972) 2.84
Patterned deposition of cells and proteins onto surfaces by using three-dimensional microfluidic systems. Proc Natl Acad Sci U S A (2000) 2.83
Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med (1995) 2.80
Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene (2010) 2.73
Nucleolar components involved in ribosome biogenesis cycle between the nucleolus and nucleoplasm in interphase cells. J Cell Biol (2001) 2.70
Metabolism of Glutamic Acid and N-Acetylglutamic Acid in Leaf Discs and Cell-free Extracts of Higher Plants. Plant Physiol (1969) 2.68
Hand-held Doppler as a screening test in primary varicose veins. Br J Surg (1997) 2.68
Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature (1998) 2.62
High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol (1997) 2.59
Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci U S A (1989) 2.59
Conversion of m-carboxyphenylalanine to m-carboxyphenylglycine in Wedgewood iris leaves. Arch Biochem Biophys (1965) 2.55
In Vivo and In Vitro Studies on gamma-Aminobutyric Acid Metabolism with the Radish Plant (Raphanus sativus, L.). Plant Physiol (1972) 2.53
Fluorescence photooxidation with eosin: a method for high resolution immunolocalization and in situ hybridization detection for light and electron microscopy. J Cell Biol (1994) 2.48
Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene (1994) 2.46
Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991. J Am Coll Surg (1995) 2.38
Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry (1993) 2.38
Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol (2004) 2.36
Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene (2011) 2.36
Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol (1988) 2.32
Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J Exp Med (1995) 2.19
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J Exp Med (1995) 2.17
Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol (1997) 2.15
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer (1998) 2.12
Crystal structure of human squalene synthase. A key enzyme in cholesterol biosynthesis. J Biol Chem (2000) 2.08
Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol (1999) 2.08
Chromatin boundaries and chromatin domains. Cold Spring Harb Symp Quant Biol (2004) 2.08
Structure of E. coli 16S RNA elucidated by psoralen crosslinking. Cell (1983) 2.07
Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene (2006) 2.07
[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Ned Tijdschr Geneeskd (2008) 2.06
Regulation of nitrate reductase in excised barley roots. Plant Physiol (1971) 2.02
Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J Biol Chem (2001) 2.02
Determination of the secondary structure of Drosophila melanogaster 5 S RNA by hydroxymethyltrimethylpsoralen crosslinking. J Mol Biol (1981) 2.01
Micropatterned surfaces for control of cell shape, position, and function. Biotechnol Prog (1998) 2.01
Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J Immunol (1995) 2.01
Influence of water deficit on maize endosperm development : enzyme activities and RNA transcripts of starch and zein synthesis, abscisic Acid, and cell division. Plant Physiol (1991) 1.98
Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene (2007) 1.98
Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med (1994) 1.95
Parathyroid carcinoma: a collective review. Ann Surg (1969) 1.94
Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg (1996) 1.91
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol (1998) 1.90
Structure and evolution of the actin gene family in Arabidopsis thaliana. Genetics (1996) 1.90
Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol (2000) 1.88
The nature of immune complexes in human cancer sera. J Immunol (1977) 1.88
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase. J Biol Chem (1998) 1.87
Role of tryptophan repeats and flanking amino acids in Myb-DNA interactions. Proc Natl Acad Sci U S A (1990) 1.84
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J (2003) 1.84
Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. Hum Mol Genet (2001) 1.84
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res (1997) 1.82
Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J (1997) 1.82
Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care (1999) 1.82
Synergistic kinetic interactions between components of the phosphorelay controlling sporulation in Bacillus subtilis. Biochemistry (1998) 1.81
Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci U S A (1994) 1.79
Differences in snRNP localization between transformed and nontransformed cells. Mol Biol Cell (1992) 1.79
Characterization and culture of sinusoidal endothelium from normal rat liver: lipoprotein uptake and collagen phenotype. Gastroenterology (1984) 1.78
Adenovirus internalization and infection require dynamin. J Virol (1998) 1.78
The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci U S A (1995) 1.77
The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol (2000) 1.77
Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells. J Biol Chem (1997) 1.76
Mammary lymphoscintigraphy in breast cancer. J Nucl Med (1995) 1.74
The biosynthesis and processing of high molecular weight precursors of soybean glycinin subunits. J Biol Chem (1982) 1.73
Complications of BCG immunotherapy in patients with cancer. N Engl J Med (1973) 1.72
Myopericytoma: a unifying term for a spectrum of tumours that show overlapping features with myofibroma. A review of 14 cases. J Clin Pathol (2006) 1.72
Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol (1998) 1.71
Radiofrequency ablation: a minimally invasive technique with multiple applications. Cancer J Sci Am (1999) 1.70
Storage Protein Composition of Soybean Cotyledons Grown In Vitro in Media of Various Sulfate Concentrations in the Presence and Absence of Exogenous l-Methionine. Plant Physiol (1984) 1.70
The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J Biol Chem (2000) 1.70